RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$327M
AUM Growth
-$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$7.18M
2 +$6.87M
3 +$6.41M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.4M
5
ALKS icon
Alkermes
ALKS
+$4.2M

Top Sells

1 +$11.5M
2 +$8.22M
3 +$7.28M
4
BIIB icon
Biogen
BIIB
+$6.95M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.58M

Sector Composition

1 Healthcare 82.32%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
26
$4.33M 1.27%
95,590
-27,830
27
$4.28M 1.25%
22,000
+500
28
$4.24M 1.24%
424,000
+24,000
29
$4.19M 1.23%
35,000
+7,000
30
$4.09M 1.2%
58,000
-2,000
31
$3.92M 1.15%
93,000
+23,000
32
$3.87M 1.13%
50,000
+21,500
33
$3.85M 1.13%
68,120
-13,624
34
$3.76M 1.1%
76,000
-28,000
35
$3.58M 1.05%
133,800
+66,300
36
$3.43M 1%
57,000
+17,000
37
$3.23M 0.95%
23,000
+8,000
38
$3.17M 0.93%
59,000
+34,000
39
$3.02M 0.88%
35,000
+3,000
40
$3M 0.88%
120,736
+13,736
41
$2.94M 0.86%
16,500
-23,500
42
$2.87M 0.84%
135,000
+48,000
43
$2.83M 0.83%
35,000
+20,000
44
$2.75M 0.81%
39,000
+29,000
45
$2.68M 0.79%
570
+468
46
$2.59M 0.76%
57,000
-33,000
47
$2.53M 0.74%
214,000
-201,000
48
$2.48M 0.73%
120,000
-20,000
49
$2.43M 0.71%
17,000
+2,000
50
$2.41M 0.71%
44,000
+14,000